Doctors head for exit at PE-backed IVF player Genea
MELBOURNE: Liverpool Partners’ IVF provider Genea has lost four of its key fertility specialists over… read more
Mesoblast surges on FDA nod for its cell therapy
MELBOURNE: Shares in Australian biopharmaceutical company Mesoblast jumped as much as 25 per cent after… read more
16 new senior healthcare executives sought for key roles
MELBOURNE: Sixteen senior healthcare, aged and retirement village executive positions remain open. New positions listed… read more
